Zevra Therapeutics CEO Neil McFarlane sells $210k in shares
NeutralFinancial Markets

Zevra Therapeutics CEO Neil McFarlane has sold $210,000 worth of shares in the company. This move is significant as it may indicate McFarlane's personal financial strategy or confidence in the company's future. Such transactions can often raise questions among investors about the leadership's commitment to the company's growth, but they are not uncommon in the corporate world.
— Curated by the World Pulse Now AI Editorial System